Company
Headquarters: Wilmington, DE, United States
$567.9 Million
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
Blackstone | $148.37 B |
BlackRock | $117.48 B |
KKR & Co. Inc. | $97.78 B |
Brookfield Corporation | $65.40 B |
The Bank of New York Mellon Corporation | $44.78 B |
Company | Market Cap (USD) |
---|---|
Berkshire Hathaway | $887.16 B |
JPMorgan | $599.29 B |
Visa | $550.38 B |
Mastercard | $416.63 B |
Bank of America | $316.02 B |
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
BlackRock Health Sciences Trust has the following listings and related stock indices.
Stock: NYSE: BME wb_incandescent